The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (2023-24)
Product name
SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial
Sponsor name
Gilead Sciences Pty Ltd
Year Range
2023-24